Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência.
Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
More men should be included in breast cancer trials to try to improve treatment for them, a British expert contends. Robert Mansel, an emeritus professor at Wales’ Cardiff University School of ... Read more
The use of artificial intelligence (A.I.) in a clinical trial matching platform led to more patients being enrolled in breast cancer studies, a Mayo Clinic oncology practice suggests. The enrollment ... Read more
The United States Mint recently released a new limited edition coin under its Breast Cancer Awareness Commemorative Coin Program to increase awareness of breast cancer and raise funds for research, according to a ... Read more
Misconceptions and fears that many breast cancer patients facing radiation therapy have are typically not realized because of modern techniques, researchers report. Indeed, an overwhelming majority of patients surveyed for this study — ... Read more
Marine-derived omega-3 fatty acids have a stronger punch than flaxseed and other oils in cancer prevention, being eight times more effective at inhibiting tumor development and growth, according to ... Read more
Novartis Canada has created a website to support women with breast cancer that has spread to other parts of the body. The site’s name, ExtraordinaryMoments.ca, spotlights one of its features — glimpses of extraordinary ... Read more
Women whose loved ones died of cancer are far more likely to consider aggressive approaches to preventing breast cancer than those whose loved ones survived the disease, an Ohio State University ... Read more
Combining OncoSec Medical‘s intratumoral therapy, ImmunoPulse IL-12, with an immune checkpoint inhibitor is a promising approach for triple-negative breast cancer patients, a Phase 1 clinical trial suggests. The approach induced ... Read more
Pin It on Pinterest